[Combined tuberculostatic therapy of laryngopulmonary tuberculosis].
D010131:Aminosalicylic Acid / Q000627:therapeutic use*; D009525:Niacin; D009539:Nicotinic Acids / Q000627:therapeutic use*; D013307:Streptomycin / Q000627:therapeutic use*; D013882:Thiosemicarbazones / Q000627:therapeutic use*; D014376:Tuberculosis; D014387:Tuberculosis, Laryngeal / Q000628:therapy*; D014397:Tuberculosis, Pulmonary / Q000628:therapy*
D009539:Nicotinic Acids; D013882:Thiosemicarbazones; D009525:Niacin; D010131:Aminosalicylic Acid; D013307:Streptomycin
NICOTINIC ACID ISOMERS/therapeutic use; PARA-AMINOSALICYLIC ACID/therapeutic use; STREPTOMYCIN/therapeutic use; THIOSEMICARBAZONES/therapeutic use; TUBERCULOSIS, LARYNGEAL/therapy; TUBERCULOSIS, PULMONARY/therapy
Ueber die kombinterte Therapie mit Tuberkulostatika bei der pulmo-laryngealen Tuberkulose.